新诺威：关于控股子公司仑卡奈单抗注射液获得药物临床试验批准通知书的公告

Group 1 - The core point of the article is that New Horizon announced the approval of a clinical trial for a drug called Lankanaib injection by the National Medical Products Administration [2] Group 2 - The approval was granted to the company's subsidiary, Shiyao Group Jushi Biopharmaceutical Co., Ltd. [2]